Kaiser Permanente is a clinical research site located in Riverside, California, United States 92505.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Kaiser Permanente has participated in 6 clinical trials with 4 currently active.
Therapeutic areas: Metastatic Prostate Cancer, Breast Neoplasms, Castration-Resistant Prostatic Cancer.
Sponsors: Janssen Research & Development, LLC, Eli Lilly and Company, Nektar Therapeutics.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Kaiser Permanente has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Kaiser Permanente has 6 clinical trials on record, with 4 currently active. Their work covers Metastatic Prostate Cancer, Breast Neoplasms, Castration-Resistant Prostatic Cancer.
Yes — Kaiser Permanente holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.